Q/C Technologies, Inc. Operating Leases, Rent Expense
Q/C Technologies, Inc. (QCLS) reported Operating Leases, Rent Expense of $40.44 thousand for the 3-month period ending 2017-06-30, per its 10-Q/A filed 2018-07-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2018-07-13
- Q/C Technologies, Inc. operating leases, rent expense for the quarter ending 2017-06-30 was $40.44K, a 0.37% increase year-over-year.
- Q/C Technologies, Inc. operating leases, rent expense for the quarter ending 2017-03-31 was $40.49K, a 0.49% increase year-over-year.
- Q/C Technologies, Inc. operating leases, rent expense for the quarter ending 2016-12-31 was $120.87K, a 199.10% increase year-over-year.
- Q/C Technologies, Inc. operating leases, rent expense for the quarter ending 2016-09-30 was -$40.29K, a 200.00% decline year-over-year.
- Q/C Technologies, Inc. operating leases, rent expense for fiscal 2016 was $161.16K, a 0.08% decline from fiscal 2015.
- Q/C Technologies, Inc. operating leases, rent expense for fiscal 2015 was $161.28K, a 0.00% change from fiscal 2014.
- Q/C Technologies, Inc. operating leases, rent expense for fiscal 2014 was $161.28K, a 8.54% increase from fiscal 2013.
- Q/C Technologies, Inc. operating leases, rent expense for fiscal 2013 was $148.59K.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 3 month as first filed | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 6 month as first filed | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 9 month as first filed | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-06-30 | $40.44K 10-Q/A · filed 2018-07-13 | $80.93K 10-Q/A · filed 2018-07-13 | $201.80K derived: sum of 3 quarters · filed 2018-07-13 | $161.51K derived: sum of 4 quarters · filed 2018-07-13 | ||||
| 2017-03-31 | $40.49K 10-Q · filed 2017-05-15 | $161.36K derived: sum of 2 quarters · filed 2017-05-15 | $121.07K derived: sum of 3 quarters · filed 2017-05-15 | $161.36K derived: sum of 4 quarters · filed 2018-07-13 | ||||
| 2016-12-31 | $120.87K derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-11 | $80.58K derived: sum of 2 quarters · filed 2017-04-11 | $120.87K derived: sum of 3 quarters · filed 2018-07-13 | $161.16K 10-K · filed 2017-04-11 | ||||
| 2016-09-30 | -$40.29K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2018-07-13 | $40.29K 10-Q · filed 2016-11-14 | $80.70K derived: sum of 4 quarters · filed 2018-07-13 | ||||
| 2016-06-30 | $40.29K 10-Q/A · filed 2018-07-13 | $80.58K 10-Q/A · filed 2018-07-13 | $40.29K 10-Q · filed 2016-08-11 | $120.99K derived: sum of 3 quarters · filed 2018-07-13 | $161.28K derived: sum of 4 quarters · filed 2018-07-13 | |||
| 2016-03-31 | $40.29K 10-Q · filed 2017-05-15 | $80.70K derived: sum of 2 quarters · filed 2017-05-15 | $120.99K derived: sum of 3 quarters · filed 2017-05-15 | $161.28K derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | $40.41K derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-11 | $80.70K derived: sum of 2 quarters · filed 2017-04-11 | $120.99K derived: sum of 3 quarters · filed 2017-04-11 | $161.28K 10-K · filed 2017-04-11 | ||||
| 2015-09-30 | $40.29K 10-Q · filed 2015-11-13 | $80.58K derived: sum of 2 quarters · filed 2015-11-13 | $120.87K 10-Q · filed 2016-11-14 | $161.28K derived: sum of 4 quarters · filed 2016-05-12 | ||||
| 2015-06-30 | $40.29K 10-Q · filed 2015-08-18 | $80.58K 10-Q · filed 2016-08-11 | $120.99K derived: sum of 3 quarters · filed 2016-05-12 | $161.28K derived: sum of 4 quarters · filed 2016-05-12 | ||||
| 2015-03-31 | $40.29K 10-Q · filed 2016-05-12 | $40.41K 10-Q · filed 2015-05-14 | $80.70K derived: sum of 2 quarters · filed 2016-05-12 | $120.99K derived: sum of 3 quarters · filed 2016-05-12 | $161.28K derived: sum of 4 quarters · filed 2016-05-12 | |||
| 2014-12-31 | $40.41K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $80.70K derived: sum of 2 quarters · filed 2016-03-30 | $120.99K derived: sum of 3 quarters · filed 2016-03-30 | $161.28K 10-K · filed 2016-03-30 | $161.25K 10-K · filed 2015-03-23 | |||
| 2014-09-30 | $40.29K 10-Q · filed 2015-11-13 | $80.58K derived: sum of 2 quarters · filed 2015-11-13 | $120.87K 10-Q · filed 2015-11-13 | $120.95K 10-Q · filed 2014-11-13 | $157.78K derived: sum of 4 quarters · filed 2015-11-13 | |||
| 2014-06-30 | $40.29K 10-Q · filed 2015-08-18 | $80.58K 10-Q · filed 2015-08-18 | $80.67K 10-Q · filed 2014-08-12 | $117.49K derived: sum of 3 quarters · filed 2015-08-18 | $154.34K derived: sum of 4 quarters · filed 2015-08-18 | |||
| 2014-03-31 | $40.34K 10-Q · filed 2015-05-14 | $40.38K 10-Q · filed 2014-05-14 | $77.20K derived: sum of 2 quarters · filed 2015-05-14 | $114.06K derived: sum of 3 quarters · filed 2015-05-14 | $150.91K derived: sum of 4 quarters · filed 2015-05-14 | |||
| 2013-12-31 | $36.85K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23 | $73.71K derived: sum of 2 quarters · filed 2015-03-23 | $110.56K derived: sum of 3 quarters · filed 2015-03-23 | $148.59K 10-K · filed 2015-03-23 | ||||
| 2013-09-30 | $36.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $73.71K derived: sum of 2 quarters · filed 2014-11-13 | $111.74K 10-Q · filed 2014-11-13 | |||||
| 2013-06-30 | $36.85K 10-Q · filed 2014-11-13 | $37.01K 10-Q · filed 2014-08-12 | $74.88K 10-Q · filed 2014-08-12 | |||||
| 2013-03-31 | $37.88K 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |